Lineage Cell Therapeutics, Inc., Insider at OncoCyte Corp (OCX), sold 4,766,180 shares at $2.16 ($10.3M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $10.3M OCX by Insider. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.16 | 2,383,090 | $5.1M | 50.0% |
| 2 | $2.16 | 2,383,090 | $5.1M | 50.0% |
| Total | $2.16 avg | 4,766,180 | $10.3M | 100% |